ESC 365 - Efficacy and safety of dapagliflozin according to baseline blood pressure - Observations from DECLARE-TIMI 58 Trial

ESC Premium Access

Efficacy and safety of dapagliflozin according to baseline blood pressure - Observations from DECLARE-TIMI 58 Trial

Session: Blockbusters from the Young in Factors and Prevention / Preventive Cardiology

Topic: Pharmacotherapy

Speaker: Doctor R. Furtado (Sao Paulo, BR)

Event: ESC Congress 2020

Congress Presentation

About the speaker

Doctor Remo Holanda De Mendonca Furtado

Hospital Israelita Albert Einstein, Sao Paulo (Brazil)

1 presentation

0 follower

1 more presentation in this session

Impact of physical activity on all-cause mortality in European patients with atrial fibrillation: a report from the ESC-EHRA EORP AF General Long-Term Registry

Speaker: Doctor M. Vitolo (Modena, IT)

Access the full session

Blockbusters from the Young in Factors and Prevention / Preventive Cardiology

Speakers: Doctor R. Furtado, Doctor M. Vitolo

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by